Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Dr. Carrie Jose, in her latest Health and Wellness column, provides six natural ways to relieve arthritis pain - without meds ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Pain management is a chronic issue that plagues the Appalachian mountains – from pharmaceutical companies rolling out ...

Dr Arthur Winter, a radiologist at SCP Radiology says, ‘Interventional radiology has developed rapidly. Pain-management ...

In an international effort, researchers at Western University, the University of Maryland School of Dentistry (UMSOD) and Neuroscience Research Australia (NeuRA) uncovered how specific patterns in ...

Clearway Pain Solutions, a national leader in comprehensive pain management and neurological care, is pleased to announce its acquisition of Eastern Neurodiagnostic Associates P.C., a distinguished ...